HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas.

AbstractOBJECTIVE:
This study used proliferating cell nuclear antigen (PCNA) and Ki67 to evaluate and compare the in situ proliferative activity of (1) solid and multicystic and (2) unicystic ameloblastomas in an attempt to provide a scientific basis for any differences in biologic behavior that exists between these 2 groups of lesions.
STUDY DESIGN:
Twenty archival tissue sections, 10 of primary unicystic and 10 of solid and multicystic ameloblastomas, were immunohistochemically stained with PCNA and Ki67 antisera. Immunoreactivity was evaluated by the counting of cells, and the data obtained were statistically analyzed.
RESULTS:
The results showed that cellular proliferative activity varied within the ameloblastoma types. The unicystic ameloblastomas showed statistically significantly higher PCNA and Ki67 labeling indices than the solid and multicystic variant.
CONCLUSION:
There appears, therefore, to be no correlation between proliferative activity as shown by these proteins and reported biologic behavior.
AuthorsShabnum Meer, Jacqueline S Galpin, Mario Altini, Hedley Coleman, Hasiena Ali
JournalOral surgery, oral medicine, oral pathology, oral radiology, and endodontics (Oral Surg Oral Med Oral Pathol Oral Radiol Endod) Vol. 95 Issue 2 Pg. 213-21 (Feb 2003) ISSN: 1079-2104 [Print] United States
PMID12582363 (Publication Type: Journal Article)
Chemical References
  • Ki-67 Antigen
  • Proliferating Cell Nuclear Antigen
Topics
  • Ameloblastoma (chemistry, pathology)
  • Analysis of Variance
  • Cell Division
  • Humans
  • Immunohistochemistry
  • Jaw Neoplasms (chemistry, pathology)
  • Ki-67 Antigen (analysis)
  • Observer Variation
  • Proliferating Cell Nuclear Antigen (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: